Delivery Order SPE2DE21D7009-SPE2D626F03V6
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management medical devices under a fixed-price contract with economic price adjustment. The award was issued on May 8, 2025, with an ultimate completion date of May 16, 2025, and will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management solutions under contract number 4570237134. This fixed-price delivery order with economic price adjustment authority was issued on November 28, 2025, with an ultimate completion date of December 5, 2025, and will be performed in Valencia, California. The award was issued without a small business set-aside designation by the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $2,683.75 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 5, 2025. The contract employs fixed-price pricing with economic price adjustment and is issued without a small business set-aside. The work will be performed in Valencia, California, under the Defense Logistics Agency's Medical Supply Chain procurement entity....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $1,825.75 delivery order for pain management medical devices under contract 4570282591. The award, issued on November 28, 2025, with an ultimate completion date of December 5, 2025, utilizes a fixed-price contract with economic price adjustment pricing structure. The contract is not designated for any small business set-aside and will be performed in Valencia, California. This delivery order...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, has been awarded a delivery order valued at $43,751.07 for pain management medical devices and services. This fixed-price contract with economic price adjustment, awarded on September 9, 2025, with completion scheduled for September 19, 2025, represents work to be performed at the contractor's facility in Valencia, California. The contract carries no set-aside designation and is funded by the Medical Supply Chain,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,771.22 for pain management medical devices on November 28, 2025, under a Defense Logistics Agency Troop Support Medical contract. The delivery order, which is fixed-price with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025, represents a task order against the company's larger indefinite delivery contract (SPE2DE)...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F03V6Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The delivery order will be performed at the awardee's facility in Valencia, California, and no small business set-aside was utilized in this procurement. This delivery order is issued under Boston Scientific Neuromodulation Corp's larger indefinite delivery contract with the Defense Logistics Agency Troop Support Medical branch, valued at $83.1 million and extending through August 16, 2026. Under the parent SPE2DE indefinite delivery vehicle, Boston Scientific Neuromodulation Corp provides comprehensive neuromodulation solutions for non-opioid pain management, including spinal cord stimulation systems such as the RestoreSensor and Spectra WaveWriter platforms, implantable pain pumps, radiofrequency ablation devices, and associated accessories and technical support services. These solutions support military treatment facilities and Veterans Affairs medical centers nationwide, enabling service members and veterans to manage chronic pain resulting from traumatic injuries. The company's federal contract portfolio demonstrates consistent delivery of sophisticated pain management technologies and has been further complemented by participation in federally funded research exploring innovative approaches to chronic pain management through grants and sub-awards from institutions such as Case Western Reserve University and the National Institutes of Health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/27/25 |